ATA552674A - Verfahren zur herstellung von substituierten guanidinen - Google Patents

Verfahren zur herstellung von substituierten guanidinen

Info

Publication number: ATA552674A
Authority: AT; Austria
Prior art keywords: substituted guanidines; manufacturing substituted; manufacturing; guanidines; substituted
Prior art date: 1973-07-13

Application number

AT552674A

Other languages

English (en)

Other versions

AT346855B (de

Original Assignee

Smith Kline French Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-07-13

Filing date

1974-07-04

Publication date

1978-04-15

1974-07-04 Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab

1978-04-15 Publication of ATA552674A publication Critical patent/ATA552674A/de

1978-11-27 Application granted granted Critical

1978-11-27 Publication of AT346855B publication Critical patent/AT346855B/de

Links

150000002357 guanidines Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT552674A 1973-07-13 1974-07-04 Verfahren zur herstellung von substituierten guanidinen AT346855B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB3342873A GB1431589A (en)	1973-07-13	1973-07-13	Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Publications (2)

Publication Number	Publication Date
ATA552674A true ATA552674A (de)	1978-04-15
AT346855B AT346855B (de)	1978-11-27

Family

ID=10352834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT552674A AT346855B (de)	1973-07-13	1974-07-04	Verfahren zur herstellung von substituierten guanidinen

Country Status (31)

Country	Link
US (1)	US4499101A (de)
JP (1)	JPS5830314B2 (de)
AR (3)	AR204928A1 (de)
AT (1)	AT346855B (de)
BE (1)	BE816850A (de)
BG (1)	BG25792A3 (de)
CA (1)	CA1049524A (de)
CH (1)	CH601252A5 (de)
CS (1)	CS199255B2 (de)
DD (1)	DD112449A5 (de)
DE (1)	DE2433625A1 (de)
DK (1)	DK334674A (de)
EG (1)	EG11259A (de)
ES (3)	ES428246A1 (de)
FI (1)	FI213274A (de)
FR (1)	FR2274298A1 (de)
GB (1)	GB1431589A (de)
HU (1)	HU169394B (de)
IE (1)	IE39607B1 (de)
IL (1)	IL45006A (de)
IN (1)	IN140943B (de)
LU (1)	LU70507A1 (de)
MW (1)	MW2674A1 (de)
NL (1)	NL7408942A (de)
NO (1)	NO143063C (de)
OA (1)	OA04814A (de)
PH (1)	PH11618A (de)
PL (3)	PL96460B1 (de)
SE (1)	SE416202B (de)
SU (3)	SU559647A3 (de)
ZM (1)	ZM10374A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4215125A (en)	1973-07-13	1980-07-29	Smith Kline & French Laboratories Limited	Pyridyl ureas, thioureas and guanidines
US4062967A (en) *	1974-02-07	1977-12-13	Smith Kline & French Laboratories Limited	Bis-guanidino-alkane compounds
US4151289A (en)	1975-01-22	1979-04-24	Smith Kline & French Laboratories Limited	Nitromethylene amidino derivatives containing imidazole groups
US4120972A (en)	1975-02-03	1978-10-17	Smith Kline & French Laboratories Limited	Imidazolylmethylthio-ethyl isothiourea compounds
GB1542840A (en) *	1975-02-03	1979-03-28	Smith Kline French Lab	Heterocyclic dithiocarbamates and isothioureas
IL49528A (en)	1975-05-21	1980-11-30	Smith Kline French Lab	Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4165378A (en)	1977-04-20	1979-08-21	Ici Americas Inc.	Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en)	1977-04-20	1980-02-21	Ici Ltd	Guanidino derivatives and pharmaceutical compositions
US4233302A (en)	1977-12-23	1980-11-11	Glaxo Group Limited	Amine derivatives and pharmaceutical compositions containing them
US4309435A (en)	1978-10-16	1982-01-05	Imperial Chemical Industries Ltd.	Antisecretory guanidine derivatives and pharmaceutical compositions containing them
JPS5610175A (en) *	1979-07-06	1981-02-02	Fujisawa Pharmaceut Co Ltd	Preparation of imidazole derivative
EP0050407A1 (de) *	1980-08-27	1982-04-28	Glaxo Group Limited	3,5-Disubstituierte-1,2,4-Triazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0089765A3 (de) *	1982-03-17	1984-05-23	Smith Kline & French Laboratories Limited	Pyridin-Derivate
DE3512084A1 (de) *	1985-04-02	1986-10-09	Ludwig Heumann & Co GmbH, 8500 Nürnberg	Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0199845B1 (de)	1985-04-02	1990-08-01	HEUMANN PHARMA GMBH & CO	Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3631334A1 (de) *	1986-09-15	1988-03-17	Heumann Pharma Gmbh & Co	Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
WO1992015567A1 (en) *	1991-02-27	1992-09-17	Seed Capital Investment (Sci) B.V.	Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor
NL9100365A (nl) *	1991-02-27	1992-09-16	Seed Capital Investments	Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
CA2307597A1 (en) *	1997-10-21	1999-04-29	Cambridge Neuroscience, Inc.	Pharmaceutically active compounds and methods of use
US7041702B1 (en)	1997-10-21	2006-05-09	Scion Pharmaceuticals, Inc.	Pharmaceutically active compounds and methods of use
EP4196793A1 (de)	2020-08-11	2023-06-21	Université de Strasbourg	Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL292485A (de) *	1962-05-09
CH484918A (de) *	1965-10-28	1970-01-31	Ciba Geigy	Verfahren zur Herstellung heterocyclischer, Aethylendoppelbindungen enthaltender Verbindungen
US3770755A (en) *	1967-09-26	1973-11-06	Ici Ltd	4-(4-bromophenyl)-2-(2-hydroxysopropyl) thiazole
US3868457A (en) *	1969-10-29	1975-02-25	Smith Kline French Lab	Method of inhibiting histamine activity with guanidine compounds
BE758146A (fr) *	1969-10-29	1971-04-28	Smith Kline French Lab	Derives de l'amidine
US3749728A (en) *	1972-02-15	1973-07-31	Smith Kline French Lab	N-cycloalkyl and n-cycloalkane-alkylthioamides
US3821229A (en) *	1972-12-07	1974-06-28	American Cyanamid Co	Diquaternary salts of di-4-pyridyl ketone
US4013659A (en) *	1973-07-13	1977-03-22	Smith Kline & French Laboratories Limited	Certain n,n'-disubstituted guanidine compounds and their use
US4156727A (en) *	1975-07-31	1979-05-29	Smith Kline & French Laboratories Limited	Alkoxy pyridine compounds

1973
- 1973-07-13 GB GB3342873A patent/GB1431589A/en not_active Expired
1974
- 1974-01-01 AR AR254698A patent/AR204928A1/es active
- 1974-06-11 IL IL45006A patent/IL45006A/xx unknown
- 1974-06-19 MW MW26/74*UA patent/MW2674A1/xx unknown
- 1974-06-21 DK DK334674A patent/DK334674A/da not_active Application Discontinuation
- 1974-06-21 PH PH15964A patent/PH11618A/en unknown
- 1974-06-25 ZM ZM103/74A patent/ZM10374A1/xx unknown
- 1974-06-25 BE BE145878A patent/BE816850A/xx not_active IP Right Cessation
- 1974-06-28 FR FR7422670A patent/FR2274298A1/fr active Granted
- 1974-07-02 NL NL7408942A patent/NL7408942A/xx not_active Application Discontinuation
- 1974-07-04 AT AT552674A patent/AT346855B/de not_active IP Right Cessation
- 1974-07-05 JP JP49077751A patent/JPS5830314B2/ja not_active Expired
- 1974-07-06 EG EG260/74A patent/EG11259A/xx active
- 1974-07-09 CH CH943074A patent/CH601252A5/xx not_active IP Right Cessation
- 1974-07-11 CA CA204,550A patent/CA1049524A/en not_active Expired
- 1974-07-11 FI FI2132/74A patent/FI213274A/fi unknown
- 1974-07-11 LU LU70507A patent/LU70507A1/xx unknown
- 1974-07-12 SU SU2043788A patent/SU559647A3/ru active
- 1974-07-12 DD DD179888A patent/DD112449A5/xx unknown
- 1974-07-12 SE SE7409188A patent/SE416202B/xx not_active IP Right Cessation
- 1974-07-12 DE DE2433625A patent/DE2433625A1/de not_active Withdrawn
- 1974-07-12 IE IE1480/74A patent/IE39607B1/xx unknown
- 1974-07-12 PL PL1974172671A patent/PL96460B1/pl unknown
- 1974-07-12 NO NO742563A patent/NO143063C/no unknown
- 1974-07-12 PL PL1974183273A patent/PL98609B1/pl unknown
- 1974-07-12 HU HUSI1421A patent/HU169394B/hu unknown
- 1974-07-12 OA OA55247A patent/OA04814A/xx unknown
- 1974-07-12 CS CS744991A patent/CS199255B2/cs unknown
- 1974-07-12 PL PL1974183272A patent/PL98705B1/pl unknown
- 1974-07-13 BG BG7400027239A patent/BG25792A3/xx unknown
- 1974-07-13 ES ES428246A patent/ES428246A1/es not_active Expired
- 1974-07-18 IN IN1600/CAL/1974A patent/IN140943B/en unknown
1975
- 1975-05-13 AR AR258761A patent/AR202617A1/es active
- 1975-05-13 AR AR258762A patent/AR202618A1/es active
- 1975-05-19 ES ES437770A patent/ES437770A1/es not_active Expired
- 1975-05-19 ES ES437769A patent/ES437769A1/es not_active Expired
- 1975-09-04 SU SU7502168215A patent/SU571193A3/ru active
- 1975-09-05 SU SU7502169007A patent/SU567405A3/ru active
1983
- 1983-02-04 US US06/463,768 patent/US4499101A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PL98705B1 (pl)	1978-05-31
EG11259A (en)	1977-01-31
NO742563L (de)	1975-02-10
ZM10374A1 (en)	1975-04-21
JPS5830314B2 (ja)	1983-06-28
SE7409188L (sv)	1975-01-14
AT346855B (de)	1978-11-27
LU70507A1 (de)	1974-11-28
HU169394B (de)	1976-11-28
IL45006A (en)	1978-07-31
ES437769A1 (es)	1977-02-01
IN140943B (de)	1977-01-01
SU571193A3 (ru)	1977-08-30
BE816850A (fr)	1974-12-27
ES428246A1 (es)	1976-07-16
NO143063B (no)	1980-09-01
SU559647A3 (ru)	1977-05-25
CS199255B2 (en)	1980-07-31
SE416202B (sv)	1980-12-08
JPS5032174A (de)	1975-03-28
OA04814A (fr)	1980-10-31
PL98609B1 (pl)	1978-05-31
CH601252A5 (de)	1978-06-30
AR204928A1 (es)	1976-03-19
DE2433625A1 (de)	1975-01-30
NL7408942A (nl)	1975-01-15
AU6984574A (en)	1975-12-11
IL45006A0 (en)	1974-09-10
US4499101A (en)	1985-02-12
BG25792A3 (en)	1978-12-12
FI213274A (de)	1975-01-14
ES437770A1 (es)	1977-01-16
DD112449A5 (de)	1975-04-12
FR2274298A1 (fr)	1976-01-09
NO143063C (no)	1980-12-10
MW2674A1 (en)	1975-05-13
AR202618A1 (es)	1975-06-24
AR202617A1 (es)	1975-06-24
GB1431589A (en)	1976-04-07
IE39607B1 (en)	1978-11-22
SU567405A3 (ru)	1977-07-30
CA1049524A (en)	1979-02-27
PL96460B1 (pl)	1977-12-31
FR2274298B1 (de)	1978-07-21
PH11618A (en)	1978-04-12
DK334674A (de)	1975-03-03
IE39607L (en)	1975-01-13

Legal Events

Date	Code	Title	Description
1984-01-15	ELJ	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
AT335755B (de)	1977-03-25	Verfahren zur herstellung von verbundstoffen
AT337153B (de)	1977-06-10	Verfahren zur herstellung von malonsauredinitril
AT346855B (de)	1978-11-27	Verfahren zur herstellung von substituierten guanidinen
AT347611B (de)	1979-01-10	Verfahren zur herstellung von neuen d-homo-20- ketopregnanen
AT342016B (de)	1978-03-10	Verfahren zur herstellung von citral
AT333954B (de)	1976-12-27	Verfahren zur herstellung von alpha-6-deoxytetracyclinen
AT333300B (de)	1976-11-10	Verfahren zur herstellung von neuen hydroxyalkylxanthinen
AT336634B (de)	1977-05-10	Verfahren zur herstellung von poly-n-alkyliminoalanen
AT337989B (de)	1977-07-25	Verfahren zur herstellung von polyamiden
AT335456B (de)	1977-03-10	Verfahren zur herstellung von cyanpyridinen
AT340043B (de)	1977-11-25	Verfahren zur herstellung von alfa-6-deoxytetracyclinen
AT343629B (de)	1978-06-12	Verfahren zur herstellung von 2-arylpropionaldehyden
AT339877B (de)	1977-11-10	Verfahren zur herstellung von cyansaure
AT335176B (de)	1977-02-25	Verfahren zur herstellung von resolen
AT340884B (de)	1978-01-10	Verfahren zur herstellung von substituierten alkinolen
AT338763B (de)	1977-09-12	Verfahren zur herstellung von alfa-athinylbenzhydrolen
AT346275B (de)	1978-11-10	Verfahren zur herstellung von briketts
ATA652574A (de)	1976-08-15	Verfahren zur herstellung von 6-methyl-5-hepten-2-onverfahren zur herstellung von 6-methyl-5-hepten-2-on
AT335588B (de)	1977-03-25	Verfahren zur herstellung von waschmitteln
AT333983B (de)	1976-12-27	Verfahren zur herstellung von glaziovin
AT343583B (de)	1978-06-12	Verfahren zur herstellung von ketoalkylxanthinen
ATA562274A (de)	1977-04-15	Verfahren zur herstellung von neuen bis-triazinobenzimidazolen
AT329534B (de)	1976-05-10	Verfahren zur herstellung von vinylcycloalkanen
AT333955B (de)	1976-12-27	Verfahren zur herstellung von transplantationsfordernden antiseren
AT337708B (de)	1977-07-11	Verfahren zur herstellung von phthalobis-guanaminen